Closure procedures for monotone bi-factorial dose-response designs

M Hellmich1, W Lehmacher

  • 1Institute of Medical Statistics, Informatics, and Epidemiology, University of Cologne, D-50924 Cologne, Germany. martin.hellmich@medizin.uni-koeln.de

Biometrics
|March 2, 2005
PubMed

Insights

This study introduces methods for multiple-dose factorial trials to identify optimal drug dosages. It focuses on finding safe and effective dose ranges while ensuring strong control of statistical error rates.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Pharmacometrics

Background:

  • Multiple-dose factorial trials aim to prove combination therapy effectiveness and determine optimal dose ranges.
  • Establishing safe and effective dose ranges is crucial for drug development.
  • Statistical methods are needed to control error rates in complex trial designs.

Purpose of the Study:

  • To present closure procedures for bi-factorial dose-response designs that guarantee strong control of the familywise error rate.
  • To investigate two families of null hypotheses for identifying minimum and maximum effective doses.
  • To demonstrate the application of these methods in an unbalanced clinical trial.

Main Methods:

  • Utilizing closure procedures to ensure strong control of the familywise error rate.
  • Applying likelihood ratio tests and multiple contrast tests.
  • Investigating bi-factorial dose-response designs with monotone properties.

Main Results:

  • The proposed methods effectively address the dual goals of demonstrating combination effectiveness and identifying dose ranges.
  • Two distinct families of null hypotheses allow for the identification of minimum and maximum effective doses.
  • The methods were successfully applied to a real-world unbalanced clinical trial example.

Conclusions:

  • The developed statistical procedures provide a robust framework for dose-finding in factorial trials.
  • These methods enhance the precision and reliability of identifying optimal therapeutic doses.
  • The availability of R code facilitates the practical implementation of these advanced statistical techniques.

Related Concept Videos

Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...